NEXTCURE INC (NXTC) Stock Fundamental Analysis

NASDAQ:NXTC • US65343E2072

13.73 USD
-0.54 (-3.78%)
Last: Feb 20, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, NXTC scores 2 out of 10 in our fundamental rating. NXTC was compared to 521 industry peers in the Biotechnology industry. The financial health of NXTC is average, but there are quite some concerns on its profitability. NXTC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NXTC has reported negative net income.
  • NXTC had a negative operating cash flow in the past year.
  • In the past 5 years NXTC always reported negative net income.
  • In the past 5 years NXTC always reported negative operating cash flow.
NXTC Yearly Net Income VS EBIT VS OCF VS FCFNXTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • NXTC's Return On Assets of -146.44% is on the low side compared to the rest of the industry. NXTC is outperformed by 83.49% of its industry peers.
  • NXTC's Return On Equity of -245.33% is on the low side compared to the rest of the industry. NXTC is outperformed by 70.63% of its industry peers.
Industry RankSector Rank
ROA -146.44%
ROE -245.33%
ROIC N/A
ROA(3y)-53.01%
ROA(5y)-39.92%
ROE(3y)-61.74%
ROE(5y)-45.48%
ROIC(3y)N/A
ROIC(5y)N/A
NXTC Yearly ROA, ROE, ROICNXTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • NXTC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXTC Yearly Profit, Operating, Gross MarginsNXTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, NXTC has more shares outstanding
  • Compared to 5 years ago, NXTC has more shares outstanding
  • NXTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NXTC Yearly Shares OutstandingNXTC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
NXTC Yearly Total Debt VS Total AssetsNXTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -18.01, we must say that NXTC is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -18.01, NXTC is doing worse than 81.38% of the companies in the same industry.
  • NXTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.01
ROIC/WACCN/A
WACCN/A
NXTC Yearly LT Debt VS Equity VS FCFNXTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.97 indicates that NXTC has no problem at all paying its short term obligations.
  • NXTC has a Current ratio of 2.97. This is in the lower half of the industry: NXTC underperforms 64.30% of its industry peers.
  • A Quick Ratio of 2.97 indicates that NXTC has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.97, NXTC is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.97
NXTC Yearly Current Assets VS Current LiabilitesNXTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • NXTC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.87%.
EPS 1Y (TTM)3.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, NXTC will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.72% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y31.73%
EPS Next 2Y28.33%
EPS Next 3Y22.78%
EPS Next 5Y13.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXTC Yearly Revenue VS EstimatesNXTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2028 2029 2030 10M 20M 30M 40M
NXTC Yearly EPS VS EstimatesNXTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NXTC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXTC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXTC Price Earnings VS Forward Price EarningsNXTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXTC Per share dataNXTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

  • NXTC's earnings are expected to grow with 22.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.33%
EPS Next 3Y22.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NXTC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXTCURE INC

NASDAQ:NXTC (2/20/2026, 8:00:01 PM)

13.73

-0.54 (-3.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners32.85%
Inst Owner Change120.19%
Ins Owners1.53%
Ins Owner Change0%
Market Cap36.80M
Revenue(TTM)N/A
Net Income(TTM)-58.01M
Analysts84.44
Price Target18.02 (31.25%)
Short Float %2.22%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-59.55%
Min EPS beat(2)-139.84%
Max EPS beat(2)20.75%
EPS beat(4)2
Avg EPS beat(4)-33.67%
Min EPS beat(4)-139.84%
Max EPS beat(4)20.75%
EPS beat(8)3
Avg EPS beat(8)-27.3%
EPS beat(12)6
Avg EPS beat(12)-15.42%
EPS beat(16)8
Avg EPS beat(16)-11.11%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)35.98%
EPS NY rev (1m)0%
EPS NY rev (3m)10.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.56
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)-24.11
EYN/A
EPS(NY)-8.39
Fwd EYN/A
FCF(TTM)-18.25
FCFYN/A
OCF(TTM)-18.26
OCFYN/A
SpS0
BVpS8.82
TBVpS8.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -146.44%
ROE -245.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.01%
ROA(5y)-39.92%
ROE(3y)-61.74%
ROE(5y)-45.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.97
Altman-Z -18.01
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)30.09%
Cap/Depr(5y)71.16%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.55%
EPS Next Y31.73%
EPS Next 2Y28.33%
EPS Next 3Y22.78%
EPS Next 5Y13.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.5%
OCF growth 3YN/A
OCF growth 5YN/A

NEXTCURE INC / NXTC FAQ

What is the ChartMill fundamental rating of NEXTCURE INC (NXTC) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXTC.


What is the valuation status of NEXTCURE INC (NXTC) stock?

ChartMill assigns a valuation rating of 1 / 10 to NEXTCURE INC (NXTC). This can be considered as Overvalued.


What is the profitability of NXTC stock?

NEXTCURE INC (NXTC) has a profitability rating of 0 / 10.


What is the financial health of NEXTCURE INC (NXTC) stock?

The financial health rating of NEXTCURE INC (NXTC) is 5 / 10.